About the Clinic

Male Fertility and Peyronie's Clinic Staff

The Male Fertility and Peyronie's Clinic was founded in July of 2019 by Dr. Landon Trost in Orem, Utah.  Dr. Trost had previously served as the head of male infertility and Peyronie's Disease at the Mayo Clinic in Rochester, Minnesota, and both he and Joshua Savage had performed all of the vasectomy reversals for Mayo Clinic.  Due to family reasons, both Dr. Trost and Joshua Savage moved their practice to Orem, Utah where they were joined by Klint Brearton and Riley Warner.  The clinic specializes only in male infertility and Peyronie's Disease, which allows for a high level of specialization for these conditions.

Meet the Providers

Untitled-21

Landon Trost, MD

    • Undergraduate - Brigham Young University
    • Medical School - Tulane University
    • Urology Residency - Mayo Clinic Rochester
    • Fellowships - Tulane University, University of Florida, Memorial Sloan Kettering Cancer Center
    • Most recent role - Assistant Professor and Chief of male infertility at the Mayo Clinic in Rochester, MN

 

Untitled-18

Joshua Savage, PA-C

    • Undergraduate - Brigham Young University
    • Physician Assistant -Idaho State University
    • Most recent role - Physician Assistant in the Department of Urology at the Mayo Clinic in Rochester, MN

 

Clint Smaller

Klinton Brearton, DNP-C

    • Undergraduate/Nursing - Utah Valley University
    • Doctor of Nursing  - University of Utah
    • Most recent role - Nurse Practitioner at Revere Health in Gastroenterology

 

Untitled-22

Riley Warner, PA-C

    • Undergraduate/Paramedic - Utah Valley University
    • Physician Assistant -Loma Linda University
    • Most recent role - Physician Assistant in Pain Management, Cottonwood Heights

 

Our Innovations

ReVas

Developers of ReVas Surgical Technique (Details)

 

Improved pregnancy outcomes by roughly 8-fold during first two years after vasectomy reversal

Publication - Savage J, Manka M, Rindels T, Alom M, Sharma K, Trost L: Reinforcing vasal suture technique improves sperm concentration and pregnancy rates in men undergoing vasovasostomy for vasectomy reversal. Transl Androl Urol 2020 Feb;9(1):73-81.

Restorex Expanded 2

Inventors of RestoreX

 

A penile traction therapy used to treat penile curvature and length loss; first of its kind to work in 30-60 minutes daily

Publications - Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L: Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. J Urol. 2019 Mar 27 epub.  2 - Alom M, Sharma KL, Toussi A, Kohler T, Trost L: Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease. J Sex Med. 2019 Jun;16(6):891-900.

Epididymovasostomy

First to Publish on Office-Based Epididymovasostomies for Vasectomy Reversal

 

Significantly reduced costs of complex vasectomy reversals while avoiding risks of general anesthesia or moderate (IV) sedation

Publication - Alom M, Ziegelann M, Savage J, Miest T, Kohler TS, Trost L: Transl Androl Urol. 2017 Aug;6(4):761-772.

New Technique for Xiaflex

Development of Novel Xiaflex Injection Protocol

Significantly improved outcomes for men undergoing Xiaflex. Currently represents the largest improvements published with Xiaflex injections.

Publications - Flores A, Tyler A, Green B, et al. Improved Peyronie's Disease Curvature Outcomes Using a Novel Collagenase Administration Protocol. Urology. 2022 Oct 12.

 

Research

First to Publish Several Key Studies

Use of Xiaflex in men with ventral and congenital curves and in men with severe calcification. Validation of calcification score in men undergoing Xiaflex

Publications - Wymer K, Ziegelmann M, Savage J, Kohler T, Trost L. Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men With Peyronie's Disease. Urology. 2018 Sep: 119:109-14.  2 - Alom M, Meng Y, Sharma KL, Savage J, Kohler T, Trost L. Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie's Disease Men With Ventral Curvatures. Urology. 2019 Jul: 129:119-25.

 

glanulopexy3

Developer of Modified Glanulopexy Technique

Surgical technique used to correct glanular hypermobility at the time of penile prosthesis placement

Publication - Ziegelmann MJ, Alom M, Bole R, Kohler T, Trost L: Modified Glanulopexy Technique for Supersonic Transporter Deformity and Glanular Hypermobility in Men with Penile Prostheses. J Sex Med. 2018 Jun;15(6):914-919.

 

MIMET2

Developer of MIMET Hydrocelectomy Technique

Improved outcomes and reduced complications for hydrocelectomy

Publication - Ziegelmann M, Dodge N, Alom M, Wymer K, Kohler T, Trost L: Urology. 2020 Jan;135:159-164.

Media Reports Featuring Our Team

Untitled-11

Affiliate Partners

Laboratory and Procedural Services Logo

We partner with Laboratory and Procedural Services to help provide laboratory testing and surgical procedures.  The relationship is similar to the affiliation which exists between hospitals and clinics to provide a diversity of medical services.

Our Publications

Full Length, Peer-Reviewed, Original Articles

  1. Flores A, Tyler A, Green B, Price T, Savage J, Brearton K, Helo S, Ziegelmann M, Kohler T, Trost L: Improved Peyronie’s disease curvature outcomes using a novel collagenase administration protocol. Urology 2022 Oct.
  2. Wittmann D, Mehta A, McCaughan E, Faraday M, Duby A, Matthew A, Incrocci L, Burnett A, Nelson CJ, Elliott S, Koontz BF, Bober S, McLeod D, Capogross P, Yap T, Higano C, Loeb S, Capellari E, Glode M, Goltz H, Howell D, Kirby M, Bennet N, Trost L, Odiyo Ouma P, Wang R, Salter C, Skolarus TA, McPahil J, McPhail S, Brandon J, Northouse LL, Paich K, Pollack CE, Shifferd J, Erickson K, Mulhall JP: Guidelines for sexual health care for prostate cancer patients: recommendations of an international panel. 2022 J Sex Med.
  3. Bivalacqua TJ, Allen BK, Brock GB, Broderick GA, Chou R, Kohler TS, Mulhall JP, Oristaglio J, Rahimi LL, Rogers ZR, Terlecki RP, Trost L, Yafi FA, Bennett NE Jr: The diagnosis and management of recurrent ischemic priapism, priapism in sickle cell patients, and non-ischemic priapism: an AUA / SMSNA guideline. J Urol 2022 July.
  4. Trost L, Huang H, Han X, Burudpakdee C, Hu Y: Penile surgery for patients with Peyronie’s disease initially treated with collagenase clostridium histolyticum or surgery: a claims database analysis. Int J Impot Res 2022 Jan.
  5. Bivalacqua TJ, Allen BK, Brock G, Broderick GA, Kohler TS, Mulhall JP, Oristaglio J, Rahimi LL, Rogers ZR, Terlecki RP, Trost L, Yafi FA, Bennett NE Jr: Acute ischemic priapism: an AUA / SMSNA guideline. J Urol 2021 Nov.
  6. Toussi A, Ziegelmann M, Yang D, Manka M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L: Efficacy of a novel penile traction device in improving penile length and erectile function post-prostatectomy: results from a single-center randomized, controlled trial. J Urol 2021 Aug.
  7. Alom M, Burgon H, Ziegelmann M, Kohler T, Helo S, Trost L: Continuing collagenase clostridium histolyticum injections among initial nonresponders results in significant curvature improvements in the majority of Peyronie’s Disease men. J Sex Med 2021 June.
  8. Liu JL, Chu KY, Gabrielson AT, Wang R, Trost L, Broderick G, Davies K, Brock G, Mulhall J, Ramasamy R, Bivalacqua TJ: Restorative therapies for erectile dysfunction: position statement from the Sexual Medicine Society of North America (SMSNA). Sex Med 2021 June.
  9. Trost L, Huang H, Han X, Burudpakdee C, Hu Y: Treatment patterns and healthcare outcomes with collagenase clostridium histolyticum vs surgery in Peyronie’s Disease: a retrospective claims database analysis. Sex Med 2021 Mar.
  10. Bole R, Jimbo M, Parikh N, Britton C, Gopalakrishna A, Yang D, Trost L, Helo S, Kohler TS, Ziegelmann MJ: Patient attitudes towards surgical management of Peyronie’s Disease prior to men’s health consultation. Urology 2021 Mar.
  11. Yang D, Savage J, Kohler T, Helo S, Trost L, Ziegelmann M: Vascular necrosis of the upper extremity after self-treatment for Peyronie’s Disease. Sex Med 2021 Feb.
  12. Bole R, Ziegelmann M, Gopalakrishna A, Collins CS, Alom M, Trost L, Helo S, Kohler TS: Predictors of patient willingness to consider surgery prior to consultation at sexual health clinic. Urology 2021 Jan.
  13. Sharma KL, Bole R, Yang D, Alom M, Savage J, Ziegelmann M, Trost L: Conservative management of suspected fractures in men undergoing collagenase clostridium histolyticum for Peyronie’s Disease is not associated with worsening of erectile function. Int J Impot Res 2020 Dec.
  14. Joseph J, Ziegelmann MJ, Alom M, Savage J, Kohler TS, Trost L: Outcomes of RestoreX penile traction therapy in men with Peyronie’s Disease: results from open label and follow-up phases. J Sex Med 2020 Dec.
  15. Manka MG, Miller A, Sharma V, Butaney M, Trost L, Ziegelmann M: Discrepancy between post-vasectomy semen analysis recommendation and practice patterns in the post-2012 American Urological Association guideline era. J Urol 2020 Dec.
  16. Nguyen HMT, Yousif A, Chung A, Virasoro R, Tapscott A, Ziegelmann M, Trost L, Gelbard M, Hellstrom WJG: Safety and efficacy of collagenase clostridium histolyticum in the treatment of acute phase Peyronie’s Disease: a multi-institutional analysis. Urology 2020 Nov.
  17. Manka MG, Yang D, Andrews J, Chalmers B, Hebert K, Kohler TS, Trost L: Intraoperative use of betadine irrigation is associated with a 9-fold increased likelihood of penile prosthesis infection: results from a retrospective case-control study. Sex Med 2020 Jun.
  18. Gopalakrishna A, Bole R, Alom M, Meng Y, Jimbo M, Trost L, Helo S, Kohler T, Ziegelmann M: Characteristics of men who are bothered by rapid ejaculation: results from clinical intake surveys. Int J Impot Res 2020 Apr.
  19. Jimbo M, Alom M, Pfeizer ZD, Haile ES, Stephens DA, Gopalakrishna A, Ziegelmann MJ, Viers BR, Trost LW, Kohler TS: Prevalence of predictors of climacturia and associated patient/partner bother in patients with history of definitive therapy for prostate cancer. J Sex Med 2020 Jun.
  20. Wittmann D, Khera M, Trost L, Mulhall J: Contemporary considerations in the pathophysiology of low sex drive in men. J Sex Med 2020 Jun.
  21. Zhang X, Zhou B, Kopecky SL, Trost LW: Two-dimensional penile ultrasound vibro-elastography for measuring penile tissue vibroelasticity: a pilot patient study and its correlation with penile ultrasonography. J Mech Behav Biomed Mater 2020 Mar.
  22. Ziegelmann MJ, Heslop D, Houlihan M, Bajic P, Helo S, Trost L, Kohler T: The influence of indentation deformity on outcomes with intralesional collagenase clostridium histolyticum monotherapy for Peyronie’s Disease. Urology Feb 2020.
  23. Savage J, Manka M, Rindels T, Alom M, Sharma KL, Trost L: Reinforcing vasal suture technique improves sperm concentration and pregnancy rates in men undergoing vasovasostomy for vasectomy reversal. Transl Androl Urol 2020 Feb.
  24. Boeri L, Palmisano F, Preto M, Sibona M, Capograsso P, Franceschelli A, Ruiz-Castane E, Sarquella-Geli J, Bassas-Arnau L, Scroppo FI, Sacca A, Gentile G, Falcone M, Timpano M, Ceruti C, Gadda F, Trost L, Colombo F, Rolle L, Gontero P, Montorsi F, Sanchez-Curbelo J, Salonia A, Montanari E: Sperm retrieval rates in non-mosaic Klinefelter patients undergoing testicular sperm extraction: What expectations do we have in the real-life setting? Andrology 2020 Jan.
  25. Ziegelmann MJ, Trost LW, Russo GI, Levine LA: Peyronie’s disease intervention studies: an exploration of modern-era challenges in study design and evaluating treatment options. J Sex Med 2020 Jan.
  26. Westerman ME, Maldonado F, Andrews JR, Sharma V, Trost L, Ziegelmann MJ: Intercourse frequency among men presenting to a sexual health clinic: does age matter? Int J Impot Res 2020 Jan.
  27. Trost L: Consenting the patient for penile implant surgery. J Sex Med 2020 Jan.
  28. Ziegelmann M, Dodge N, Alom M, Wymer K, Kohler T, Trost L: Office-based, minimal-incision modified fenestration technique (MIMFeT) for symptomatic hydroceles under local anesthesia. Urology 2019 Oct.
  29. Trost L: Future considerations in prosthetic urology. Asian J Androl 2019 Oct
  30. Sharma KL, Alom M, Trost L: The etiology of Peyronie’s Disease: pathogenesis and genetic contributions. Sex Med Rev 2019 Sep.
  31. Wymer K, Kohler T, Trost L: Comparative cost-effectiveness of surgery, collagenase clostridium histolyticum, and penile traction therapy in men with Peyronie’s Disease in an era of effective clinical treatment. J Sex Med 2019 Sep.
  32. Alom M, Sharma KL, Toussi A, Kohler T, Trost L: Efficacy of combined collagenase clostridium histolyticum and Restorex penile traction therapy in men with Peyronie’s Disease. J Sex Med 2019 Apr.
  33. Ziegelmann M, Savage J, Toussi A, Alom M, Yang D, Kohler T, Trost L: Outcomes of a novel penile traction device (RestoreX) in men with Peyronie’s disease: a randomized, single-blinded, controlled trial. J Urol 2019 Mar.
  34. Alom M, Meng Y, Sharma KL, Savage J, Kohler T, Trost L: Safety and efficacy of collagenase clostridium histolyticum in Peyronie’s disease men with ventral curvatures. Urology 2019 Mar. Epub.
  35. Hellstrom WJG, Tue Nguyen HM, Alzweri L, Chung A, Virasoro R, Tapscott A, Ziegelmann M, Trost L, Gelbard M: Intralesional collagenase clostridium histolyticum causes meaningful improvement in men with Peyronie’s Disease: results of a multi-institutional analysis. J Urol 2019 Jan. Epub.
  36. Meng Y, Yang DY, Hebert KM, Savage JB, Alom M, Kohler TS, Trost L: What about the partner? Factors associated with patient-perceived dyspareunia in men with Peyronie’s disease. Transl Androl Urol 2018 Dec.
  37. Clavell Hernandez J, Trost L, Kohler T, Ring J, Traweek R, Alom M, Wang R: Emerging complications following alternative reservoir placement during inflatable penile prosthesis placement: a 5-year multi-institutional experience. J Urol 2018 Oct [epub]
  38. Trost L, Zitzmann M: Testosterone therapy: do American and European clinicians have different approaches? J Sex Med 2018 [epub].
  39. Mulhall JP, Giraldi A, Hackett G, Hellstrom WJF, Jannini EA, Rubio-Aurioles E, Trost L, Hassan TA: The 2018 revision to the process of care model for evaluation of erectile dysfunction. J Sex Med 2018 July [epub]
  40. Mulhall JP, Giraldi A, Hackett G, Hellstrom WJG, Jannini EA, Rubio-Aurioles E, Trost L, Hassan TA: The 2018 revision to the process of care model for management of erectile dysfunction. J Sex Med 2018 July [epub]
  41. Armstrong JM, Avant RA, Charchenko CM, Westerman ME, Ziegelmann M, Miest TS, Trost LW: Impact of anabolic androgenic steroids on sexual function. Transl Androl Urol. 2018 June.
  42. Avant RA, Charchenko CM, Alom M, Westerman ME, Maldonado F, Miest T, Trost L. Medication patterns and fertility rates in a cohort of anabolic steroid users. Transl Androl Urol. 2018 May.
  43. Wymer K, Ziegelmann M, Savage J, Kohler T, Trost L: Plaque calcification: An important predictor of collagenase clostridium histolyticum treatment outcomes for men with Peyronie’s disease. Urology 2018 Jun [epub]
  44. Bole R, Ziegelmann M, Avant R, Montgomery B, Kohler T, Trost L: Patient’s choice of health information and treatment modality for Peyronie’s disease: a long-term assessment. Int J Impot Res 2018 May.
  45. Montgomery BD, Lomas DJ, Ziegelmann MJ, Trost LW: Infection risk of undergoing multiple penile prostheses: an analysis of referred patient surgical histories. Int J Impot Res 2018 May.
  46. Ziegelmann MJ, Alom M, Bole R, Kohler T, Trost L: Modified glanulopexy technique for supersonic transporter deformity and glanular hypermobility in men with penile prostheses. J Sex Med. 2018 May [epub].
  47. Avant RA, Ziegelmann M, Nehra A, Alom M, Kohler T, Trost L: Penile traction therapy and vacuum erection devices in Peyronie’s disease. Sex Med Rev 2018 Apr [epub]. *Highlighted in UroToday.
  48. Mulhall JP, Trost LW, Brannigan RE, Kurtz EG, Redmon JB, Chiles KA, Lightner DJ, Miner MM, Murad MH, Nelson CJ, Platz EA, Ramanathan LV, Lewis RW: Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol 2018 Mar.
  49. Zhang X, Zhou B, Miranda A, Trost LW: A novel non-invasive ultrasound vibro-elastography technique for assessing patients with erectile dysfunction and peyronie’s disease. Urology 2018 Mar.
  50. Ziegelmann M, Bole R, Avant R, Yang D, Montgomery B, Trost L: Conservatively managed Peyronie’s disease – long-term survey results from patients electing non-surgical and non-injection therapies. Urology 2018 Mar.
  51. Ziegelmann MJ, Alom M, Hebert K, Avant R, Kohler T, Trost L: Clinical factors negatively impacting sexual relationships in men with Peyronie’s disease. J Sex Marital Ther. 2017 Nov.
  52. Alom M, Ziegelmann M, Savage J, Miest T, Kohler TS, Trost L: Office-based andrology and male infertility procedures – a cost effective alternative. Transl Androl Urol. 2017 Aug.
  53. Gupta NK, Ring J, Trost L, Wilson SK, Kohler TS: The penoscrotal approach for inflatable penile prosthesis placement. Transl Androl Urol. 2017 Aug.
  54. Ziegelmann M, Kohler TS, Bailey GC, Miest T, Alom M, Trost L: Surgical patient selection and counseling. Transl Androl Urol. 2017 Aug.
  55. Bhindi B, Wallis CJD, Nayan M, Farrell AM, Trost LW, Hamilton RJ, Kulkarni GS, Finelli A, Fleshner NE, Boorjian SA, Karnes, RJ: The association between vasectomy and prostate cancer: a systematic review and meta-analysis. JAMA Intern Med. 2017 July.
  56. Ziegelmann MJ, Viers BR, Montgomery BD, Westerman ME, Savage JB, Trost LW: Self-reported clinical meaningfulness early in the treatment course predicts objective outcomes in men undergoing collagenase clostridium histolyticum injections for Peyronie’s disease. Urology 2017 May.
  57. Yafi FA, Haney NM, Anaissie J, DeLay KJ, Trost L, Khera M, Hellstrom WJG: Practice patterns in the diagnosis and management of hypogonadism: a survey of sexual medicine society of north America members. Urology 2017 May.
  58. Ziegelmann MJ, Viers BR, Montgomery BD, Avant RA, Savage JB, Trost LW: Clinical experience with penile traction therapy among men undergoing collagenase clostridium histolyticum for Peyronie’s disease. Urology. 2017 Mar.
  59. Boonjindasup A, Pinsky M, Stewart C, Trost L, Chaffin A, Jansen D, Hellstrom W: Management of adult concealed penis using a meshed, split-thickness skin graft. Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E407-411.
  60. Trost LW, Munarriz R, Wang R, Morey A, Levine L: External mechanical devices and vascular surgery for erectile dysfunction. J Sex Med. 2016 Nov;13(11):1579-1617.
  61. Ziegelmann MJ, Viers BR, Lomas DJ, Westerman ME, Trost LW: Ectopic penile prosthesis reservoir placement: an anatomic cadaver model of the high submuscular technique. J Sex Med. 2016 Sep;13(9):1425-31.
  62. Trost LW, Mulhall JP: Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials. J Sex Med. 2016 May – epub. *Highlighted in UroToday.
  63. Levine LA, Becher E, Bella A, Brant W, Kohler T, Martinez-Salamanca JL, Trost L, Morey A: Penile prosthesis surgery: current recommendations from the international consultation on sexual medicine. J Sex Med. 2016 Apr; 13(4):489-518.
  64. Westerman ME, Charchenko CM, Ziegelmann MJ, Bailey GC, Nippoldt TB, Trost L: Heavy testosterone use among bodybuilders: an uncommon cohort of illicit substance users. Mayo Clin Proc. 2016 Feb;91(2):175-82.
  65. Yafi FA, Hatzichristodoulou G, Knoedler CJ, Trost LW, Sikka SC, Hellstrom WJ: Comparative analysis of tunical plication vs intralesional injection therapy for ventral Peyronie’s disease. J Sex Med. 2015 Dec [epub].
  66. Trost L, Wanzek P, Bailey G: A practical overview of considerations for penile prosthesis placement. Nat Rev Urol. 2015 Dec [epub].
  67. Trost L, Patil M, Kramer A: Critical appraisal and review of management strategies for severe fibrosis during penile implant surgery. J Sex Med. 2015 Nov;12 Suppl 7:439-47.
  68. Ziegelmann MJ, Viers BR, McAlvany KL, Bailey GC, Savage JB, Trost LW: Restoration of penile function and patient satisfaction with intralesional collagenase clostridium histolyticum injection for Peyronie’s disease. J Urol. 2015 Oct [epub].
  69. Stewart CA, Yafi FA, Knoedler M, Mandava SH, McCaslin IR, Sangkum P, Sikka S, Trost L, Hellstrom WJ: Intralesional injection of interferon-alpha2b improves penile curvature in men with Peyronie’s disease independent of plaque location. J Urol. 2015 Dec;194(6):1704-7.
  70. Yafi FA, Pinsky MR, Stewart C, Sangkum P, Ates E, Trost LW, Sikka SC, Hellstrom WJ: The effect of duration of penile traction therapy in patients undergoing intralesional injection therapy for Peyronie’s disease. J Urol. 2015 Mar.
  71. Aliperti LA, Lasker GF, Hagan SS, Hellstrom JA, Gokce A, Trost LW, Kadowitz PJ, Sikka SC, Hellstrom WJ: Efficacy of pioglitazone on erectile function recovery in a rat model of cavernous nerve injury. Urology. 2014 Nov;84(5):1122-7.
  72. Trost LW, Boonjindasup AG, Hellstrom WJ: Comparison of infrapubic versus transscrotal approaches for inflatable penile prosthesis placement: a multi-institution report. Int J Impot Res. 2014. Epub. *Highlighted in MDLinx.com
  73. Serefoglu EC, Trost L, Sikka SC, Hellstrom WJ: The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie’s disease. Int J Impot Res. 2014. Epub.
  74. Trost LW, Khera M: Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul;15(7):417. *Highlighted in MDLinx.com and UroToday
  75. Bailey GC, Trost LW: Current diagnosis and management of premature ejaculation. Current Sexual Health Reports. 2014 Jun;6(2):65-80.
  76. Gokce A, Abd Elmageed ZY, Lasker GF, Bouljihad M, Kim H, Trost LW, Kadowitz PJ, Abdel-Mageed AB, Sikka SC, Hellstrom WJ: Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie’s disease. Andrology. 2014 Mar;2(2):244-51.
  77. Trost L, Parekattil S, Wang J, Hellstrom WJ: Intra-corporeal robotic-assisted microsurgical vasovasostomy for the treatment of bilateral vasal obstruction occurring following bilateral inguinal hernia repairs with mesh placement. J Urol. 2013 Dec
  78. Kaag M, Trost L, Thompson RH, Favaretto R, Elliott V, Shariat SF, Maschino A, Vertosick E, Raman JD, Dalbagni G: Pre-operative predictors of renal function decline following radical nephroureterectomy for upper tract urothelial carcinoma. BJU Int. 2013 Dec
  79. Saitz TR, Serefoglu EC, Trost LW, Thomas R, Hellstrom WJ: The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer. Andrology. 2013 Nov;1(6):859-63. *Highlighted in MDLinx.
  80. Aliperti LA, Trost LW, Hellstrom WJG: Collagenase clostridium histolyticum: a novel nonsurgical option for the treatment of Peyronie’s disease. Int J Clin Rheum. 2013 Oct;8(5):531-540.
  81. Garaffa G, Trost LW, Serefoglu EC, Ralph D, Hellstrom WJ: Understanding the course of Peyronie’s disease. Int J Clin Pract. 2013 Aug;67(8):781-8
  82. Smith WB 2nd, McCaslin IR, Gokce A, Mandava SH, Trost L, Hellstrom WJ: PDE5 inhibitors: considerations for preference and long-term adherence. Int J Clin Pract. 2013 Aug;67(8):768-80.
  83. Trost LW, Hellstrom WJG: History, contemporary outcomes, and future of penile prostheses: a review of the literature. Sex Med Rev. 2013 May;1(3):150-63.
  84. Trost LW, Ates E, Powers M, Gur S, Sikka S, Hellstrom WJ: Outcomes of intralesional interferon alpha-2b for the treatment of Peyronie’s disease. J Urol. 2013 May;epub. *Highlighted in Reuters Health
  85. Trost LW, McCaslin R, Linder B, Hellstrom WJ: Long-term outcomes of penile prostheses for the treatment of erectile dysfunction. Expert Rev Med Devices. 2013 May;10(3):353-66.
  86. Trost L, Saitz, TR, Hellstrom WJG: Side effects of 5-alpha reductase inhibitors: a comprehensive review. Sex Med Rev 2013;1:24-41.
  87. Trost LW, Baum N, Hellstrom WJG: Managing the difficult penile prosthesis patient. J Sex Med. 2013 Apr;10(4):893-907. *Highlighted in MDLinx.com. **Highlighted in UroToday
  88. Mandava SH, Trost LW, Hellstrom WJG: Critical analysis of surgical outcomes for the treatment of Peyronie’s Disease. Arab J Urol. 2013 Mar;11(3):284-93.
  89. Trost LW, Serefoglu E, Gokce A, Linder BJ, Sartor AO, Hellstrom WJ: Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement. J Sex Med. 2013 Feb;10 Suppl 1:84-101. *Highlighted in UroToday.
  90. Serefoglu EC, Saitz TR, Trost L, Hellstrom WJ: Premature Ejaculation: Do We Have Effective Therapy? Transl Androl Urol 2013 Jan;2(1):45-53.
  91. Trost L, Elliott D: Male stress urinary incontinence: a review of surgical treatment options and outcomes. Adv Urol. 2012;2012:287489. *Highlighted in UroToday with commentary January 17, 2013
  92. Trost L, Brannigan R: Oncofertility and the male cancer patient. Curr Treat Options Oncol. 2012 Jun;13(2):146-60.
  93. Trost L, Elliott D: Small intestinal submucosa urethral wrap at the time of artificial urinary sphincter placement as a salvage treatment option for patients with persistent / recurrent incontinence following multiple prior sphincter failures and erosions. Urology 2012 Apr;79(4):933-8. Epub 2011 Nov 25.  *Highlighted in UroToday with commentary February 2012.
  94. Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH. High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma.  2012 Mar; 79(3):615-9.
  95. Trost LW, Nehra A: Guideline based management of male infertility: Why do we need it? Indian J Urol. 2011 Jan;27(1):49-57.
  96. Viers B, Trost LW, Kramer S: Ectopic ureter in an adolescent female presenting with primary nocturnal enuresis and new onset urinary incontinence. J Urol Feb;185(2):689. Epub 2010 Dec 18.
  97. Kendirci M, Trost L, Bakondi B, Whitney MJ, Hellstrom WJ, Spees JL: Transplantation of nonhematopoietic adult bone marrow stem/progenitor cells isolated by p75 nerve growth factor receptor into the penis rescues erectile function in a rat model of cavernous nerve injury. J Urol.  2010 Oct;184(4):1560-6.
  98. Kendirci M, Trost L, Sikka SC, Hellstrom WJ: The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol. 2007 Dec;178(6):2516-20.
  99. Gur S, Kadowitz PJ, Trost L, Hellstrom WJG: Optimizing Nitric Oxide Production by Time Dependent L-arginine Administration in Isolated Human Corpus Cavernosum. J Urol. 2007 Oct;178(4):1543-8.
  100. Kendirci M, Pradhan L, Trost L, Chandra S, Agrawal KC, Hellstrom WJG: Peripheral mechanisms of erectile dysfunction in a rat model of binge cocaine use. Eur Urol 2007, doi:10.1016/j.eururo.2007.03.022.
  101. Trost L, Siddiqui SA, Gettman M: Cystolithiasis with concentric mural calcification following transurethral microwave thermotherapy. J Urol.  2007 Jun;177(6):2339
  102. Reddy D, Trost LW, Lee T, Baluch AR, Kaye AD: Rheumatoid arthritis: current pharmacologic treatment and anesthetic considerations. Middle East J Anesthesiol. 2007 Jun;19(2):311-33
  103. Trost L, Gur S, Hellstrom WJG: Pharmacological management of Peyronie’s Disease. Drugs 2007 Mar;67(4):527-45.
  104. Trost LW, Kivilcim M, Peyman GA, Aydin E, Kazi AA: The effect of intravitreally injected povidone-iodine on staphylococcus epidermidis in rabbit eyes. J Ocul Pharmacol Ther 2007 Feb;23(1):70-7.
  105. Kendirci M, Trost L, Sikka S, Hellstrom WJG: Diabetes mellitus is associated with severe Peryonie’s disease. BJU Int 2007 Feb;99(2):383-6.
  106. Kendirci M, Tanriverdi O, Trost L, Hellstrom WJG: Management of sildenafil treatment failures. Curr Opin Urol 2006 Nov;16(6):449-59.
  107. Trost L, Kendirci M, Hellstrom W: Erectile Dysfunction in the aging man: current options for treatment. Aging Health 2006 Feb;2(1):1-16.
  108. Cicerone MT, Tellington A, Trost L, Sokolov A: Substantially improved stability of biological agents in dried form: the role of glassy dynamics in preservation of biopharmaceuticals. Bioprocess International 1, 2-16 (2003).

Trost LW, Steele FM: Control of microbiological losses prior to cane delivery, and during sugar processing. Int Sugar J 2002;104(1239):118-123.

Presentations at Regional, National, or International Meetings

Invited Lectures:

  1. Traction therapy should be offered as a standard of care option in PD therapy – Pro – SMSNA – Oct 2022.
  2. Changing to a clinic-based operative practice: lessons learned – SMSNA – Oct 2022.
  3. Penile traction therapy – from gimmick to legitimate therapy – Urologic society of Australia and New Zealand – Jun 2022.
  4. Health risks no provider should miss in men presenting with sexual dysfunction or infertility – AUA – May 2022.
  5. Updates on penile traction therapy – UCI International Mens Health Course – Jan 2022.
  6. Industry sponsored research should not be published in medical journals – SMSNA Oct 2021.
  7. Testosterone and advanced / metastatic prostate cancer – SMSNA Oct 2021.
  8. Prostate Cancer Forum – Sexual Dysfunction and Best Treatments in 2021 – AUA Sept 12, 2021.
  9. Only treat low T if two values <300 ng/dl: pro position – AUA Sept 11, 2021
  10. Shockwave therapy, stem cells, and platelet rich plasma for ED: cutting edge or 2021 snake oil? – 25th Congress of the World Association for Sexual Health Sept 10, 2021.
  11. Collagenase clostridium histolyticum as first-line therapy for PD – Mayocon webinar Oct 18, 2020
  12. Medical management and intralesional injection therapies – Mayocon webinar Oct 18, 2020
  13. Reviewing a scientific manuscript – SMSNA webinar Sept 3, 2020.
  14. Low sexual desire in men: non-psychological etiologies and treatments – ISSM webinar Aug 27, 2020.
  15. Painful, smelly, discolored, or bloody ejaculation: best practices – AUA State of the Art Lecture June, 2020 (virtual due to coronavirus).
  16. Shock wave therapy, stem cells, and platelet rich plasma for ED – cutting edge or 2020 snake oil? Utah Urological Society March 2020 Salt Lake City, UT.
  17. Panel – When should ED trigger a cardiology referral / workup. SMSNA Oct, 2019 Nashville, TN.
  18. Debate – Is Mondor’s Disease the underlying cause of Peyronie’s Disease – con position. SMSNA Oct, 2019 Nashville, TN.
  19. Historical and Contemporary Management of Peyronie’s Disease.  SMSNA Oct, 2019 Nashville, TN.
  20. Low sexual desire / interest. AUA May, 2019 Chicago, IL.
  21. New hypermobile glans correction technique and other office-based urology procedures. AUA May, 2019 Chicago, IL.
  22. Male infertility - apathy or ignorance, who knows, who cares? Mayo Clinic Ob/Gyn Clinical and Surgical Updates Feb 2019 Dana Point, CA.
  23. AUA Testosterone Guidelines. SMSNA Nov, 2018 Miami, FL.
  24. Writing a Paper. SMSNA Nov, 2018 Miami, FL.
  25. Survivor debate: Peyronie's disease. AUA May, 2018 San Francisco, CA.
  26. 2nd opinion cases (ask the guidelines): testosterone replacement. AUA May, 2018 San Francisco, CA.
  27. Testosterone therapy is associated with increased cardiovascular risk: pro position. AUA May, 2018 San Francisco, CA.
  28. AUA guidelines update - Hibernian urological society. AUA May, 2018 San Francisco, CA.
  29. Intralesional collagenase: on-label and off-label protocols. AUA - SMSNA meeting.  May 2018 San Francisco, CA.
  30. Shockwave therapy for ED: ready for routine practice? International Society for Sexual Medicine Bi-annual Meeting, Mar 2, 2018 Lisbon, Portugal.
  31. Simplified infertility workup. Mayo Clinic Reviews in Urology.  Jan, 2018 Maui, Hawaii.
  32. Latest in erectile dysfunction. Mayo Clinic Reviews in Urology. Jan, 2018 Maui, Hawaii.
  33. Medical management of male infertility. ASRM Nov, 2017 San Antonio, TX.
  34. Penile Doppler: Tips / Tricks / Techniques. SMSNA Oct, 2017 San Antonio, TX.
  35. Natural History of Peyronie's Disease. SMSNA Oct, 2017 San Antonio, TX.
  36. A How-to Video Guide for Novel Surgical Approaches: Office Based Andrologic Procedures. SMSNA Oct, 2017 San Antonio, TX.
  37. Testosterone - Hanz and Franz or Gandolf? Clinical Reviews in Internal Medicine, Oct 23 and Nov 6, 2017, Rochester, MN.
  38. Treatment of Human Papilloma Virus. AUA May, 2017 Boston, MA.
  39. Evidence Against Testosterone Therapy in Prostate Cancer. AUA May, 2017 Boston, MA.
  40. Evidence Based Review of Risks and Benefits of Testosterone Supplementation. 37th Annual Ralph E. Hopkins Urology Seminar in Jackson Hole, WY. Feb 2017.
  41. Should CCH be Considered 1st Line Therapy for PD? 37th Annual Ralph E. Hopkins Urology Seminar in Jackson Hole, WY. Feb 2017.
  42. Alternative Forms of Testosterone Supplementation: The Role for Selective Estrogen Receptor Modulators and Aromatase Inhibitors. 37th Annual Ralph E. Hopkins Urology Seminar in Jackson Hole, WY. Feb 2017.
  43. Selecting Appropriate Candidates for Penile Prostheses: How to Avoid the CURSED Penis. 37th Annual Ralph E. Hopkins Urology Seminar in Jackson Hole, WY. Feb 2017.
  44. The Natural History of Peyronie's Disease. 37th Annual Ralph E. Hopkins Urology Seminar in Jackson Hole, WY. Feb 2017.
  45. Take home messages - androgens. SMSNA in Scottsdale, AZ.
  46. Peyronie's disease evaluation and treatment. SMSNA in Scottsdale, AZ.
  47. Take home messages - erectile and ejaculatory dysfunction. 20th World Meeting on Sexual Medicine. Beijing, China. Sept 2016.
  48. AMN and erectile dysfunction: maintaining quality of life. The United Leukodystrophy Foundation, Omaha, NE. July 2016.
  49. Penile rehabilitation is beneficial after pelvic oncology surgery: con position. AUA in San Diego, CA. May 2016
  50. Erectile dysfunction in the man with low testosterone. Plenary 2nd opinion cases - benign. AUA in San Diego, CA. May 2016.
  51. Off-label Management of Testosterone Deficiency: HCG / Clomid. SMSNA in Las Vegas, NV. Nov 2015.
  52. Things to Look for in a Fellowship. SMSNA in Las Vegas, NV. Nov 2015.
  53. Take Home Message: Sexual Function and Dysfunction. AUA in New Orleans, LA. May 2015.
  54. Penile Implant Should be Offered Early. AUA in New Orleans, LA. May 2015.
  55. Surgical Techniques in Andrology Update 2015. MUS in Minneapolis, MN. Mar 2015.
  56. Update on Androgen Replacement Therapy. MUS in Minneapolis, MN. Mar 2015.
  57. CURSED Penis: The importance of patient selection. SMSNA in Miami, FL. Nov 2014.
  58. Penile Rehabilitation: The science and evidence. APN-PA Symposium SMSNA in Miami, FL. Nov 2014
  59. Diagnosis and Treatment of Low testosterone. Geriatric Update for the Primary Care Provider in Rochester, MN. Nov 2014.
  60. Sex Rehab after Radical Prostatectomy: Is it Really Justified? Con Position. ISSM in Sao Paulo, Brazil. Oct 2014.
  61. Peyronie's Disease Pharmacotherapy and Traction Therapy. ISSM in Sao Paulo, Brazil. Oct 2014.
  62. Take Home Message: Erectile Dysfunction. ISSM in Sao Paulo, Brazil. Oct 2014.
  63. Testosterone Replacement: Myths and Controversies. Mayo Clinic Alumni Association Meeting in Dublin, Ireland. Sept 2014.
  64. Male Sexual Disorders: More than Just Erectile Dysfunction. Mayo Clinic Alumni Association Meeting in Edinburgh, Scotland. Sept 2014.
  65. Peyronie's Disease. Presented for the "Drive for Men's Health" event. June 2014.
  66. The Natural History of Peyronie's Disease. Presented at AUA - SMSNA - SUPS in Orlando, FL. May 2014.
  67. Take Home Message: Sexual Function / Dysfunction. Presented at AUA in Orlando, FL. May 2014.
  68. Should Testosterone Level Measurement be a Standard Annual Screening Test for Men Over 40 Years of Age? Presented at the Sexual Medicine Society Annual Meeting in New Orleans, LA.  Nov 2013.
  69. Robotic Microsurgery Training. Presented at Robotic Assisted Microsurgical and Endoscopy Society in Strasbourg, France. Nov 2013.
  70. Post Prostatectomy Management of Erectile Dysfunction: What to Do. Presented at World Congress of Endourology in New Orleans, LA. Oct 2013.
  71. Surgical Treatment of Peyronie's Disease. Presented at Asia Pacific Society for Sexual Medicine Meeting in Manado, Indonesia. Oct 2013.
  72. Surgical Tips with Penile Prosthesis Insertion: Challenging Cases. Presented at Asia Pacific Society for Sexual Medicine Meeting in Manado, Indonesia. Oct 2013.
  73. How to Identify and Handle the Difficult Implant Patient. Presented at Louisiana State Urological Society annual meeting in Shreveport, LA. April 2013.
  74. Do 5-Alpha Reductase Inhibitors (5-ARI) Really Cause Persistent Sexual Dysfunction? Presented at Louisiana State Urological Society annual meeting in Shreveport, LA. April 2013.
  75. New Concepts for Priapism. Presented at International Congress of Andrology in Melbourne, Australia. Feb 2013.
  76. Gene Therapy, Stem Cells, and Tissue Regeneration for Erectile Dysfunction: Past, Present, and Future. Presented at International Congress of Andrology in Melbourne, Australia. Feb 2013.
  77. Training in Robotic Microsurgery. Presented at Robotic Assisted Microsurgical and Endoscopy Society in Tampa, FL. Nov 2012.
  78. Infertility: a review of the physiology, etiology, diagnosis, and treatment options. Presented at the Society of Urologic Nurses and Associates in Rochester, MN. April 2011.
  79. Urothelial cell carcinoma: a review of the history, diagnosis, peri-operative care and future direction. Presented at the Society of Urologic Nurses and Associates in Rochester, MN. April 2010. 

 

Podium Presentations:

  1. Anderson N, Green B, Savage J, Brearton K, Ziegelmann M, Helo S, Kohler T, Trost L: CLINiC score – a novel prediction model of collagenase clostridium histolyticum outcomes in men with Peyronie’s disease. SMSNA Oct 2022.
  2. Palmer B, Anderson N, Green B, Savage J, Brearton K, Ziegelmann M, Helo S, Kohler T, Trost L: Efficacy of a novel collagenase clostridium histolyticum protocol for Peyronie’s disease among prior non-responders: a randomized, controlled, single-blinded study. SMSNA Oct 2022.
  3. Warner J, Green B, Anderson N, Savage J, Brearton K, Ziegelmann M, Helo S, Kohler T, Trost L: Comparison of collagenase clostridium histolyticum to surgery for the management of Peyronie’s disease: a randomized trial. SMSNA Oct 2022.
  4. Zganjar A, Toussi A, Ziegelmann M, Yang D, Manka M, Kohler T, Helo S, Trost L: Efficacy of Restorex PTT in improving penile length and erectile function post-prostatectomy. AUA May 2022.
  5. Green B, Francis M, Savage J, Brearton K, Tyler A, Trost L: Comparison of collagenase clostridium histolyticum to surgery for the management of Peyronie’s disease: a randomized trial. AUA May 2022.
  6. Tyler A, Green B, Savage J, Brearton K, Trost L: Improved Peyronie’s disease curvature outcomes using a more aggressive technique. AUA May 2022.
  7. Ziegelmann M, Liu G, McLane M, Hu Y, Trost L: Collagenase clostridium histolyticum treatment for Peyronie’s disease: an analysis of outcomes and cumulative benefits after each injection cycle. SMSNA Oct 2021.
  8. Zganjar A, Toussi A, Ziegelmann M, Yang D, Manka M, Kohler T, Helo S, Trost L: Efficacy of Restorex PTT in improving penile length and erectile function post-prostatectomy. SMSNA Oct 2021.
  9. Price T, Burgon H, Green B, Brearton K, Savage J, Ziegelmann M, Kohler T, Trost L: Changes in point of maximal curvature during CCH injections for Peyronie’s disease. SMSNA Oct 2021.
  10. Burgon H, Tyler A, Green B, Savage J, Brearton K, Granberg C, Ziegelmann M, Kohler T, Helo S, Trost L: Outcomes of CCH in men with congenital penile curvature. SMSNA Oct 2021.
  11. Tyler A, Green B, Savage J, Brearton K, Burgon H, Trost L: Improved Peyronie’s disease curvature outcomes using a more aggressive technique. SMSNA Oct 2021.
  12. Price T, Burgon H, Green B, Brearton K, Savage J, Ziegelmann M, Kohler T, Trost L: Changes in point of maximal curvature during CCH injections for Peyronie’s disease. AUA Sept 2021.
  13. Yang D, Toussi A, Savage J, Zieglemann M, Kohler T, Trost L: Use of RestoreX penile traction therapy for treatment of penile length loss in diabetic men. SMSNA Nov 2020 Virtual Meeting.
  14. Yang D, Toussi A, Savage J, Zieglemann M, Kohler T, Trost L: Efficacy of RestoreX penile traction therapy in improving penile length and erectile function post prostatectomy. SMSNA Nov 2020 Virtual Meeting.
  15. Toussi A, Savage J, Trost L: Efficacy of RestoreX penile traction therapy in improving penile length and erectile function post prostatectomy. WSAUA Nov 2019 Monterey, CA.
  16. Toussi A, Savage J, Alom M, Sharma K, Ziegelmann M, Trost L: Efficacy of RestoreX penile traction therapy in improving penile length and erectile function post prostatectomy. SMSNA Oct, 2019 Nashville, TN.
  17. Alom M, Sharma K, Ziegelmann M, Savage J, Kohler T, Trost L: Should men with poor results after two series of collagenase injections for Peyornie’s Disease continue therapy? SMSNA Oct, 2019 Nashville, TN.
  18. Yang D, Meng Y, Savage J, Wymer K, Kohler T, Trost L: Impact of penile traction therapy on erectile dysfunction in a cohort of men with Peyronie's disease. Presented at AUA in Chicago, IL May 2019
  19. Andrews J, Manka M, Kohler T, Trost L: Intra-operative use of betadine is associated with an increased rate of penile prosthesis infections. Presented at SESAUA in Phoenix, AZ Mar 2019.
  20. Ziegelmann M, Savage J, Avant R, Yang D, Kohler T, Trost L: Preliminary 3-month outcomes of a novel penile traction device (RestoreX) in men with Peyronie's Disease: a randomized, controlled trial. Presented at SMSNA in Miami, FL Nov 2018.
  21. Miller A, Sharma V, Ziegelmann M, Trost L: Discrepancy between vasectomy guidelines and practice patterns in the post 2012 AUA guideline era: what have we learned? Presented at AUA in San Francisco, CA, May 2018.
  22. Hebert K, Ziegelmann M, Maldonado F, Miest T, Andrews J, Bole R, Alom M, Trost L: Alcohol use and sexual health concerns in a sexual health clinic. Presented at NCS in Scottsdale, AZ, Nov 2017.
  23. Alom M, Ziegelmann M, Avant R, Bole R, Kohler T, Trost L: The impact of sexual dysfunction on sexual relationships. Presented at SMSNA in San Antonio, TX, Oct 2017. Selected as one of top 10 overall abstracts of meeting.
  24. Meng Y, Ziegelmann M, Trost L: What about the partner? Factors associated with partner dyspareunia in men with Peyronie's disease. Presented at SMSNA in San Antonio, TX, Oct 2017. Selected as one of top 10 resident abstracts of meeting.
  25. Westerman ME, Charchenko C, Alom M, Maldonado F, Miest T, Trost L: Medication patterns and fertility rates in a cohort of anabolic steroid users. Presented at AUA in Boston, MA, May 2017.
  26. Ziegelmann M, Bole R, Avant R, Montgomery B, Alom M, Trost L: The natural history of untreated Peyronie's disease: curvature, length, and pain. Presented at AUA in Boston, MA, May 2017. Highlighted by Medscape
  27. Ziegelmann M, Viers B, Montgomery B, Savage J, Trost L: Concurrent penile traction therapy in men undergoing collagenase clostridium histolyticum for Peyronie's disease. Presented at AUA in Boston, MA, May 2017.
  28. Ziegelmann M, Viers B, Montgomery B, Avant R, Trost L: Penile traction does not improve outcomes with collagenase clostridium histolyticum for the treatment of Peyronie's disease. Presented at SMSNA in Scottsdale, AZ, Nov 2016. Best abstract.
  29. Montgomery B, Trost L: Characteristics and infection risk in patients undergoing multiple inflatable penile prostheses. Presented at NCS in Chicago, IL, Sept 2016.
  30. Ziegelmann M, Trost L: Outcomes of men undergoing in-office hydrocelectomy under local anesthesia. Presented at NCS in Chicago, IL, Sept 2016.
  31. Ziegelmann M, Viers B, Montgomery B, Westerman MB, Avant R, Trost L: Self-reported clinical meaningfulness predicts objective outcomes in men undergoing collagenase clostridium histolyticum injections for Peyronie's disease. Presented at NCS in Chicago, IL, Sept 2016.
  32. Ziegelmann MJ, Viers BR, Lomas DJ, Westerman ME, Trost LW: Submuscular ectopic inflatable penile prosthesis reservoir placement: a cadaveric study of anatomic location. Presented at SMSNA in Las Vegas, NV. Nov 2015.
  33. Trost LW and Mulhall JM: Frequency of citation errors among male sexual medicine publications in high-impact urology journals. Presented at ISSM in Sao Paulo, Brazil. Oct 2014.
  34. Trost LW, Peak T, Tan R, Sikka S, Hellstrom WJG: Efficacy of penile traction therapy among patients undergoing intralesional interferon treatment for Peyronie's disease. Presented at AUA in Orlando, FL. May 2014.
  35. Trost L, Boonjindasup A, Gokce A, Hellstrom WJG: Comparison of infrapubic versus transcrotal approaches for inflatable penile prosthesis placement: a multi-institution report. Presented at ASA in San Antonio, TX. April 2013.
  36. Powers M, Trost L, Caire A, Hellstrom WJG: Success rate of intralesional interferon injections for reducing curvature in patients with Peyronie's Disease. Presented at SESAUA in Williamsburg, VA. March 2013. Trost presenting.
  37. Boonjindasup A, Pinsky M, Smith B, Trost L, Jansen D, Hellstrom WJG: Management of concealed penis using meshed split-thickness skin grafting in an adult population. Presented at SESAUA in Williamsburg, VA. March 2013. Boonjindasup presenting.
  38. Trost L, Elliott D: Long term results of small intestinal submucosa at artificial urinary sphincter placement for management of persistent / recurrent incontinence following multiple prior sphincter failures and erosions. Presented at NCS in Rancho Mirage, CA. Oct 2011
  39. Trost L, Elliott D: SIS urethral wrap as a salvage treatment for patients with recurrent incontinence following multiple prior failed AUS and erosions. Presented at AUA in Washington D.C. May 2011
  40. Trost L, Shanafelt T, Carlson R, Karnes RJ: Pre-existing or intra-operatively discovered malignant lymphoma at the time of radical prostatectomy is associated with lower overall survival without change in cancer specific survival. Presented at AUA in Washington D.C. May 2011
  41. Trost L, Elliott D: Surgisis urethral wrap is a viable treatment option for patients with persistent stress urinary incontinence following multiple prior artificial urinary sphincter failures and erosions. Presented at NCS in Chicago, IL. Sept 2010
  42. Trost L, Hellstrom W: The effect of daily versus perioperative dosing of a poly (adenosine diphosphate-ribose) polymerase inhibitor on erectile function in a bilateral, nerve-crush rat model. Presented at AUA in San Francisco, CA. May 2010
  43. Trost L, Gettman M, Schmidt S, Frank I: The Role of Mentorship in Establishing a Robotic Prostatectomy Program. Presented at the World Congress of Endourology and SWL 2008 in Shanghai, China. Dec 2008

 

Video Presentations:

  1. Ziegelmann M, Alom M, Wymer K, Kohler T, Trost L: Hydrocelectomy using a minimally-invasive, office-based approach. Video presented at AUA in San Francisco, CA. May 2018.
  2. Trost L: Hydrocelectomy - Urology Times - 2017 Nov - http://urologytimes.modernmedicine.com/urology-times/news/office-andrology-videos-show-office-based-hydrocelectomy-vasectomy-reversal
  3. Trost L: Office-based vasectomy reversal - Urology Times - 2017 Oct - http://urologytimes.modernmedicine.com/urology-times/news/office-andrology-videos-show-office-based-hydrocelectomy-vasectomy-reversal
  4. Wang J, Trost LW, Hellstrom WJG: Intra-corporeal robotic assisted vaso-vasostomy for the management of bilateral vasal obstruction following inguinal herniorrhaphy with mesh. Video presented at AUA in Orlando, FL. *Received third honorable mention. May 2014.
  5. Trost L, Elliott D: Modifications to the Virtue male sling procedure: 5-points of fixation, 1-point of plication. Video presented at AUA in San Diego, CA. *Received 1st honorable mention video awards. May 2013.
  6. Trost L, Elliott D: SIS urethral wrap at the time of repeat AUS placement following multiple prior failed AUS and erosions. Video presentation presented at AUA in Washington D.C. *Received 3rd place video awards. May 2011

 

Webinars and Podcasts:

  1. Penile length and Peyronie’s disease. Nov 2022 – Mark Goldberg
  2. Infertility and sexual medicine – Oct 2022 – ISSM Podcast Series
  3. Optimizing Outcomes for Penile Prosthesis. Nov 2020 – ISSM
  4. Reviewing a Scientific Manuscript. Sept 2020 – SMSNA
  5. Peyronie’s Disease: Causes, Diagnosis, and Treatments. April 2020 – MenMD.
  6. Peyronie’s Disease: Causes, Diagnosis, and Treatments. Jan 2020. https://menmd.com/category/physician-articles/peyronies-disease-causes-diagnosis-and-treatments/
  7. Urology Care Foundation. Fertility Preservation and Testicular Cancer. February 2019.
  8. The link between diabetes, ED, and heart disease. June 2016.
  9. Infertility: not just a female condition. May 2015.  https://www.inciid.org/infertility-not-just-for-women

 

Courses:

  1. Trost LW: How often should IPP occur after RP? Rehab and shortening. SMSNA Miami, FL Oct 2022.
  2. Mulhall JM, Trost LW, Brannigan R: AUA guidelines 2018: the evaluation and management of testosterone deficiency: what you need to know. AUA San Francisco, CA May 2018.
  3. Parekattil S, Trost LW, Andrew McCullough: Robotic-assisted Microsurgical Training and Skills Platforms. AUA Instructional Course - Robotic Microsurgery: Male Infertility and Chronic Orchialgia. AUA San Diego, CA May 2013.
Scroll to Top